Female pharmaceutical scientist analyzing a test tube during the drug discovery process.

The skills students gain from the University of Cincinnati’s MS Pharm Sci program help them advance into other career roles.

University of Cincinnati

eLearning in the Pharmaceutical Industry: Advancing Careers Through Online Education

Boost your pharmaceutical career with an online master’s in pharmaceutical sciences. Learn drug development and precision medicine through eLearning.
| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00
A female pharmaceutical scientist analyzes a tube containing red liquid during the drug discovery process.
The University of Cincinnati’s master’s of pharmaceutical science program opens up new opportunities in the pharmaceutical industry through online learning.

Expanding Opportunities in the Pharmaceutical Industry Through eLearning

Drug development is an arduous process that can take more than a decade and involve numerous scientific, clinical, regulatory, manufacturing, and business considerations. Working in the pharmaceutical industry requires a unique interdisciplinary understanding of science and the drug development process as a whole. While professionals may wish to obtain an advanced degree, it may be unrealistic to return to school full time.


The University of Cincinnati’s Online MS in Pharmaceutical Sciences

The online master of science in pharmaceutical sciences (MS Pharm Sci) program at the University of Cincinnati engages individuals in a cross-disciplinary learning environment led by experts from industry-leading companies with real world insights. Although attending online, students have access to the same curricula and professors as students who choose to attend in person.

Comprehensive Training in Drug Development and Pharmacogenomics

The University of Cincinnati’s MS Pharm Sci program covers all phases of drug development, from drug discovery to approval and beyond. Students also have the unique opportunity to learn about drug discovery through the lens of pharmacogenomics. Understanding how genomics, the environment, and patient-specific factors affect drug responses is the next step in pharmacology and precision healthcare.

Continue reading below...
Close-up of a researcher using a stylus to draw or interact with digital molecular structures on a blue scientific interface.
ArticlesSpeaking the same molecular language in the age of complex therapeutics
When molecules outgrow the limits of sketches and strings, researchers need a new way to describe and communicate them.
Read More

Career Advancement Through Pharmaceutical eLearning

The skills students gain from the University of Cincinnati’s MS Pharm Sci program help them advance into other career roles such as research scientist, business manager, regulatory affairs specialist, and strategist. With a growing need for talent in the pharmaceutical field, this program will help individuals take their place in the drug development industry.

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Close-up of a researcher using a stylus to draw or interact with digital molecular structures on a blue scientific interface.
When molecules outgrow the limits of sketches and strings, researchers need a new way to describe and communicate them.
Portrait of Scott Weitze, Vice President of Research and Technical Standards at My Green Lab, beside text that reads “Tell us what you know: Bringing sustainability into scientific research,” with the My Green Lab logo.
Laboratories account for a surprising share of global emissions and plastic waste, making sustainability a priority for modern research.
3D illustration of RNA molecules on a gradient blue background.
With diverse emerging modalities and innovative delivery strategies, RNA therapeutics are tackling complex diseases and unmet medical needs.
Drug Discovery News September 2025 Issue
Latest IssueVolume 21 • Issue 3 • September 2025

September 2025

September 2025 Issue

Explore this issue